Ventricular activation time as a marker for diastolic dysfunction in early hypertension

American Journal of Hypertension

Volumn 23, Issue 7, 2010, Pages 781-785

  Boles, Usama ^a   Almuntaser, Ibrahim ^a   Brown, Angie ^a   Murphy, Ross R T ^a   Mahmud, Azra ^a   Feely, John ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Blood pressure; Diastolic dysfunction; Hypertension; Left ventricular hypertrophy; Tissue Doppler imaging; Ventricular activation time

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DECELERATION; DIASTOLIC DYSFUNCTION; DISEASE MARKER; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE; HEART VENTRICLE ACTIVATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OSCILLOMETRY; PRIORITY JOURNAL; QT INTERVAL; TISSUE DOPPLER IMAGING; TWO DIMENSIONAL ECHOCARDIOGRAPHY; COMPLICATION; DIASTOLE; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77953811395     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.58     Document Type: Article

References (23)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223.
2. van Heerebeek L, Borbély A, Niessen HW, Bronzwaer JG, van der Velden J, Stienen GJ, Linke WA, Laarman GJ, Paulus WJ. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006; 113:1966-1973.
3. Almuntaser I, Mahmud A, Brown A, Murphy R, King G, Crean P, Feely J. Blood pressure control determines improvement in diastolic dysfunction in early hypertension. Am J Hypertens 2009; 22:1227-1231.
4. Slama M, Susic D, Varagic J, Frohlich ED. Diastolic dysfunction in hypertension. Curr Opin Cardiol 2002; 17:368-373.
5. Suárez C, Villar J, Martel N, Extremera BG, Suliman N, Campo C, Castellanos V, Liébana A, Rodilla E, Nieto J, Velasco O, Ruilope LM; GESTHA Study Group. Should we perform an echocardiogram in hypertensive patients classified as having low and medium risk? Int J Cardiol 2006; 106:41-46.
6. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
7. Gunduz H, Binak E, Arinc H, Akdemir R, Ozhan H, Tamer A, Uyan C. The relationship between P wave dispersion and diastolic dysfunction. Tex Heart Inst J 2005; 32:163-167.
8. Kleber FX, Pfeffer MA, Pfeffer JM. Alterations in the electrocardiogram of spontaneously hypertensive rats by chronic antihypertensive therapy with captopril. Clin Exp Hypertens A 1982; 4:977-987.
9. Romhilt DW, Estes EH Jr. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 1968; 75:752-758.
10. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlöf B. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Hypertension 2000; 36:766-773.
11. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527-1533.
12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.
13. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
14. Rakowski H, Appleton C, Chan KL, Dumesnil JG, Honos G, Jue J, Koilpillai C, Lepage S, Martin R P, Mercier LA, O'Kelly B, Prieur T, Sanfilippo A, Sasson Z, Alvarez N, Pruitt R, Thompson C, Tomlinson C. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr 1996; 9:736-760.
15. Almuntaser I, Brown A, Murphy R, Crean P, King G, Mahmud A, Feely J. Comparison of echocardiographic measures of left ventricular diastolic function in early hypertension. Am J Cardiol 2007; 100:1771-1775.
16. Ommen SR, Nishimura RA, Appleton C P, Miller FA, Oh JK, Redfield MM, Tajik AJ. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation 2000; 102:1788-1794.
17. Kuznetsova T, Herbots L, López B, Jin Y, Richart T, Thijs L, González A, Herregods MC, Fagard RH, Díez J, Staessen JA. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail 2009; 2:105-112.
18. Bacharova L, Szathmary V, Kovalcik M, Mateasik A. Effect of changes in left ventricular anatomy and conduction velocity on the QRS voltage and morphology in left ventricular hypertrophy: a model study. J Electrocardiol; e-pub ahead of print 25 August 2009.
19. Maldonado Tapia B, Calderón Colmenero J, de Micheli A, Rijlaarsdam M, Casanova Garcés JM, Attie F, Buendia A. [Electrocardiography and echocardiography aspects of hypertrophic myocardiopathy in pediatrics]. Arch Inst Cardiol Mex 2000; 70:247-260.
20. Palmieri V, Okin PM, Bella JN, Wachtell K, Oikarinen L, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hypertens 2006; 24: 2079-2084. (Pubitemid 44371275)
21. Cohen GI, Pietrolungo JF, Thomas JD, Klein AL. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J Am Coll Cardiol 1996; 27:1753-1760.
22. Choong CY, Herrmann HC, Weyman AE, Fifer MA. Preload dependence of Doppler-derived indexes of left ventricular diastolic function in humans. J Am Coll Cardiol 1987; 10:800-808.
23. Gerdts E, Oikarinen L, Palmieri V, Otterstad JE, Wachtell K, Boman K, Dahlöf B, Devereux RB; Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Hypertension 2002; 39:739-743.